Are you the publisher? Claim or contact us about this channel

Embed this content in your HTML


Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog

Channel Description:

Visit One News Page for Europe news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Europe news headlines.

older | 1 | .... | 1624 | 1625 | (Page 1626) | 1627 | 1628 | .... | 1652 | newer

    0 0

    MONTREAL, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “*Company*”* or *“*Relevium*”), is pleased to announce the national screening of “Weed the People” across eight Canadian cities on January 15, 2019.Relevium Technologies, in partnership with Executive Producer Ricki Lake, Director Abby Epstein and, will be conducting a nation-wide screening of Weed the People, a compelling, emotional and educational film that explores the potential benefits of medical cannabis oils for pediatric applications. The film follows the journey of five families dealing with children suffering from cancer and the introduction of cannabis oil to treat their children following the failure of conventional treatments. The families in the documentary pursue the use of cannabis alongside conventional treatments, including chemotherapy and radiation, revealing thought-provoking outcomes that support further research and exposing the legal contextual hurdles faced by these parents as they pursue lifesaving alternatives for their children.

    Relevium Technologies recently announced the exclusive license from Cannakids’ to introduce medical cannabis formulations, SOPs and branding into the Canadian market to pursue pediatric applications and support ongoing research. Tracy Ryan, the CEO of CK Properties and its brand Cannakids, and her family are one of the five families described in the film, which also tells the story of her motivation to enter into the medical cannabis business to support her daughter’s battle against cancer.

    Aurelio Useche, CEO of Relevium Technologies stated: “The film is an amazing journey into the potential opportunities of complementing traditional treatments for Cancer and other illness in Pediatric patients.” Mr. Useche stated further: “We at Relevium are committed to introduce and further develop these possibilities, which is why we feel everyone should attend the screening of this amazing documentary, a film that not only opens a potential door for hope for patients and their families, but also further validates the legalization of Cannabis in Canada by the Canadian Government and by our prime minister Justin Trudeau.”

    Relevium Technologies would like to invite our shareholders, industry leaders, the general public as well as the medical and scientific community to the national screenings which will take place in eight (8) Canadian cities on January 15, 2019 as follows:

    * Toronto:*
     January 15th, 2019 @ 7pm 
     Cineplex Yonge-Dundas and VIP
     10 Dundas St E #402, Toronto, ON, M5B 2G9, Canada
    * Tickets:*

    * * * Vancouver:*
     January 15th, 2019 @ 7pm
     Cineplex Odeon International Village Cinemas
     International Village Mall, Vancouver, BC, V6B 6N9, Canada
    * Tickets:*

    * *
    * Montreal:*
     January 15th, 2019 @ 7pm
     Cineplex Odeon Quartier Latin Cinemas
     350 Rue Émery, Montréal, QC, H2X 1J1, Canada
    * Tickets:*

    * * * Ottawa:*
     January 15th, 2019 @ 7pm
     Cineplex Odeon South Keys Cinemas
     SmartREIT, Ottawa, ON, K1V 1J6, Canada
    * Tickets:*

    * *
    * Calgary:*
     January 15th, 2019 @ 6pm
     Cineplex Odeon Eau Claire Market Cinemas
     Eau Claire Market, Calgary, AB, T2P 4R5, Canada
    * Tickets:*

    * * * Edmonton:*
     January 15th, 2019 @ 7pm 
     Cineplex Odeon South Edmonton Cinemas
     South Edmonton Common, Edmonton, AB, T6N 1K5, Canada
    * Tickets: *

    * *
    * Winnipeg:*
     January 15th, 2019 @ 7pm
     Cineplex Odeon McGillivray Cinemas and VIP
     2190 McGillivray Blvd, Winnipeg, MB, R3Y 1S6, Canada
    * Tickets:*

    * * * ** Halifax:*
     January 15th, 2019 @ 7pm
     Cineplex Park Lane
     Park Lane Mall, Halifax, NS, B3J 3R4, Canada
    * Tickets:*


    *Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.*

    *About Abby Epstein and Ricki Lake*
    The makers of the film, Abby Epstein and Ricki Lake have produced and directed ground-breaking documentaries including "The Business of Being Born", "Sweetening the Pill", "The Mama Sherpas" and now "Weed the People".  

    Abby Epstein is a film director and producer, and an award-winning play director.  Prior to her film work, Abby directed theatre productions of "RENT" and "The Vagina Monologues."  

    Ricki Lake is an American film actress and television host best known for her starring role in the original movie "Hairspray" and for her daytime talk show, "The Ricki Lake Show" which aired for 11 seasons until 2005.  The show returned in 2012 and resulted in Ricki winning an Emmy. 

    *About Relevium Technologies*
    Relevium is a publicly-traded company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the Health and Wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly-owned subsidiaries:

    *BGX E-Health LLC (BGX): *Based in Orlando, Florida, BGX markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe. Relevium’s brands such as Bioganix® are sold at some of the world’s largest retailers including such as and

    The Company’s strategy for growing its brands includes expanding its product offering, adding new distribution channels and developing partnerships that add value through exclusive ingredients. BGX is currently testing a complete line of dietary supplements derived from Cannabis with an initial focus on hemp derived, whole plant organic extract rich in CBD (cannabidiol). The product line will be marketed through its brand LeefyLyfe® and will be sold first in Europe and then North America. The Company uses cannabinoids and ingredients that have achieved GRAS status (generally accepted as safe) to create brands that are sold via wholesale channels, retail channels and online distribution.

    *Biocannabix Health Corporation (BCX): *Based in Montreal, Quebec, BCX is an entrepreneurial venture to establish a vertically integrated research based medical cannabis company in the Nutraceutical space.

    *Cautionary Note Regarding Forward-Looking Statements*
    This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will be able to apply for and ultimately obtain an ACMPR licence, the proposed business of Biocannabix will develop as anticipated, that the Company will raise sufficient funds to develop the Biocannabix business, and that the Company will obtain all requisite regulatory approvals. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds.

    Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

    On Behalf of the Board of Directors


    Aurelio Useche
    President and CEO

    For more information about this press release:

    Tel: +1.888.528.8687
    Like us on Facebook  
    Follow us on Twitter  
    Follow us on LinkedIn Reported by GlobeNewswire 4 hours ago.

    0 0

    BeWhere Holdings Inc. Announces Proposed Private Placement *3Not for Distribution to United States Newswire Services or for Dissemination in the United States*

    *TORONTO, ON / ACCESSWIRE / January 10, 2019 / BeWhere Holdings Inc. (TSXV: BEW, OTCQB: BEWFF) *(*"BeWhere" *or the *"Company")* is pleased to announce its intention to complete a private placement equity financing of units of the Company ("*Units*") for minimum gross proceeds of $2,500,000 (the "*Minimum Offering*") and maximum gross proceeds of $3,500,000 (the "*Maximum Offering*" and collectively with the Minimum Offering, the "*Private Placement*") at a price of $0.19 per Unit.

    Each Unit will consist of one common share in the capital of the Company (a "*Common Share*") and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a "*Warrant*"). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of $0.35 for a period of 5 years following the closing of the Private Placement.

    The Company has entered into an engagement letter with PI Financial Corp. to act as lead agent (the "*Agent*") in connection with the Private Placement on a "best-efforts" basis.

    The Agent will be paid a cash commission equal to 7% of the gross proceeds of the Private Placement (3.5% in respect of President's List purchasers up to $2,500,000) and will receive broker warrants entitling the Agent to purchase a number of Common Shares equal to 7% of the number of the Units sold pursuant to the Private Placement (3.5% in respect of President's List purchasers up to $2,500,000).

    In addition, the Company has granted the Agent an over-allotment option to sell up to an additional 15% of the Units to be issued pursuant to the Private Placement, exercisable, in whole or in part, at any time up to 24 hours before the closing of the Private Placement.

    The net proceeds of the Private Placement will be used for purchase of inventory, for working capital and, if the Maximum Offering is achieved, for expansion of operations in Europe.

    The Company also announces that a strategic investor and current partner is expected to be subscribing for Units in the Private Placement in the amount of $1,000,000. Owen Moore, CEO of BeWhere Inc. said "We are pleased to expand our existing relationship with a strategic partner/investor. We have worked closely with this company during the engineering, proof of concept and commercialization of our Mobile Internet of Things (M-IOT) solutions and we are pleased to expand our relationship with the offering."

    In that directors and senior officers of the Company will be participating in part of the Private Placement, that part of the Private Placement will be a "related party transaction" within the meaning of Multilateral Instrument 61-101 ("*MI 61-101*"), which requires the Company to obtain "minority approval" of the Company's shareholders of the related party transaction unless there is an exemption from such requirement. The Company is relying on the exemption in Section 5.7(a) of MI 61-101 on the basis that the fair market value of the securities to be distributed to the related parties will be less than 25% of the Company's market capitalization.

    The Private Placement is subject to TSX Venture Exchange acceptance. The Common Shares and Warrants issued as part of the Units pursuant to the Private Placement will be subject to a four-month and a day hold period.

    This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "*U.S. Securities Act*") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

    *About BeWhere*

    BeWhere Holdings Inc. (TSXV:BEW) is an Industrial Internet of Things ("IIoT") solutions company that designs and sells hardware with sensors and software application to track real-time information on non-powered fixed and movable assets, as well as to monitor environmental conditions. The Company develops mobile applications, middle-ware and cloud-based solutions that stand-alone or that can be readily integrated with existing software. The Company's solutions use available cellular technologies (LTE-M and NB-loT) and offer customers low-cost technology to implement a new level of visibility to their businesses.

    The Company sells its products through a worldwide network of distribution and technology companies. It secured distribution agreements and technology partnerships with a large roster of companies including major telecommunications providers, leading vehicle telematics providers and logistic and supply chain management solution providers.

    *Forward-Looking Statements*

    The information and statements in this news release contain certain forward-looking information. This forward-looking information relates to future events or the Company's future performance. In particular, this document contains forward-looking information and statements regarding: (i) the completion of the Private Placement and the issuance of the Units; and (ii) the use of proceeds of the private placement. All statements other than statements of historical fact may be forward-looking information. This forward-looking information is subject to certain risks and uncertainties and may be based on assumptions that could cause actual results to differ materially from those anticipated or implied in the forward-looking information. These assumptions include market acceptance of the terms of the Private Placement and that, in respect of the use of proceeds, historical costs and expenses will be representative of future costs and expenses. The outcome and timing of the proposed Private Placement, as well as the Company's actual results, performance or achievement could differ materially from those expressed in, or implied by, such forward-looking information, and accordingly, no assurances can be given that any of the events anticipated by the forward-looking information will transpire or occur or, if any of them do, what benefits that the Company will derive from them. The Company's forward-looking information is expressly qualified in its entirety by this cautionary statement. Except as required by law, the Company undertakes no obligation to publicly update or revise any forward-looking information.


    *For further information, please contact:*

    Margaux Berry

    VP Strategy and Growth

    Tel: 1-(844) 229-4373 ext. 107

    *SOURCE:* BeWhere Holdings Inc.
    View source version on Reported by Accesswire 4 hours ago.

    0 0

    Juventus are a club on a mission. They have conquered Italy, winning the last seven Serie A titles and are set to make it eight in a row as they hold a nine-point lead this season. Juve now want to make the next step and conquer Europe. And they went about it the right way […] Reported by talkSPORT 4 hours ago.

    0 0

    At least 16 people have died after heavy snowfall continues to wreak havoc across Europe. Reported by Myjoyonline 4 hours ago.

    0 0

    FREMONT, Calif., Jan. 10, 2019 (GLOBE NEWSWIRE) -- *Aehr Test Systems (NASDAQ: AEHR), *a worldwide supplier of semiconductor test and burn-in equipment, today announced financial results for its second quarter of fiscal 2019 ended November 30, 2018.

    *Fiscal Second Quarter Financial Results:*

    · Net sales were $5.9 million, compared to $7.9 million in the second quarter of fiscal 2018.
    · GAAP net loss was $629,000, or $0.03 per diluted share, compared to GAAP net income of $60,000, or $0.00 per diluted share, in the second quarter of fiscal 2018.
    · Non-GAAP net loss, which excludes the impact of stock-based compensation expense, was $405,000, or $0.02 per diluted share, compared to non-GAAP net income of $424,000, or $0.02 per diluted share, in the second quarter of fiscal 2018.
    · Backlog as of November 30, 2018 was $4.3 million.

    *Fiscal First Six Months Financial Results:*

    · Net sales were $10.7 million, compared to $14.9 million in the first six months of fiscal 2018.
    · GAAP net loss was $2.1 million, or $0.10 per diluted share, compared to GAAP net income of $70,000, or $0.00 per diluted share, in the first six months of fiscal 2018.
    · Non-GAAP net loss was $1.7 million, or $0.07 per diluted share, compared to non-GAAP net income of $650,000, or $0.03 per diluted share, in the first six months of fiscal 2018.

    An explanation of the use of non-GAAP financial information and a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.

    *Second Quarter and Recent Business Highlights:*

    · Received an order for and shipped a follow-on FOX-XP^TM Multi-Wafer Test and Burn-in System and WaferPak^TM Aligner to the company’s lead customer for wafer level test and burn-in of silicon photonics devices.
    · Shipped follow-on ABTS^TM Test and Burn-in System to a wireless communications chipset company for use in high volume production burn-in of automotive devices.
    · Announced today the addition of a new product in Aehr Test’s FOX-P^TM platform, the FOX-NP^TM system, which increases the market opportunity for the company’s FOX^TM systems and contactors with a low cost, small footprint entry-level system that provides a configuration for initial product development, production qualification and New Production Introduction (NPI).
    · Received a commitment and expect an order imminently from a new customer to use Aehr Test’s FOX-P Platform for test and burn-in of silicon photonics devices. This additional production test and burn-in customer plans to utilize Aehr Test’s new FOX-NP system to begin their production ramp and then transition to high volume production test and burn-in of 100% of their silicon photonics devices using Aehr Test’s FOX-XP systems.
    · Appointed new Executive Vice President of Sales and Marketing to oversee all aspects of the Company’s customer facing sales, marketing and support team, including direct sales, distributors and representatives in Asia and Europe, and its subsidiaries in Japan and Germany.

    *Gayn Erickson, President and CEO of Aehr Test Systems, commented:*

    “While our revenue in the second quarter was lower on a year-over-year basis, it was in line with the expectations that we discussed in last quarter’s call for a softer first half of the fiscal year, with many of our customers’ capacity ramps expected in the second half of our fiscal year. We continue to feel positive about the second half, but there are in fact both positive and negative events that impact our expectations for the fiscal second half and full year.

    “Our lead customer for our FOX-XP system for production wafer level burn-in of silicon photonics devices continues to drive increased business for us. This customer, who is one of the world’s largest semiconductor manufacturers, has a very strong forecast for their capacity ramp, which will consume the system capacity they have ordered to date. We continue to expect orders for a significant number of our WaferPak Contactors by the end of this fiscal year to populate their FOX-XP systems, as well as orders for additional FOX-XP systems and WaferPak Contactors throughout calendar year 2019 and beyond.

    “We are pleased to announce that just this week we received a commitment from a new customer to use our FOX-P Platform for test and burn-in of silicon photonics devices. This additional production customer will utilize our new FOX-NP system to begin their production ramp and then transition to high volume production test and burn-in of 100% of their silicon photonics devices using our FOX-XP systems, which have the capacity to test and burn-in over 4,600 singulated die devices in parallel. We are expecting imminent placement of an order by this customer for their initial design verification, qualification and production needs.

    “The FOX-NP system is a new product within Aehr Test’s FOX-P family that offers a lower cost entry-level system to provide a configuration and price point for companies to do initial production qualification and new product introduction, enabling an easier transition to the FOX-XP for full production test. This new FOX-NP system is 100% compatible with the FOX-XP system and is configurable with up to two blades per system compared to up to 18 blades in the FOX-XP system.

    “As we had discussed last quarter, many of our customers had substantial forecasts for bookings and shipments that we forecasted by the end of our fiscal year. We have seen push outs of orders for capacity increases from our installed base due to customer device delays that do not appear to be related to macro industry trends. We also believe some of our customers have taken a cautious stance which has impacted the timing of their orders to Aehr due to general market concerns and trade uncertainties between the US and China, as well as slow-downs in the mobile space that have been widely reported. Specifically, we are seeing orders that are delayed such that we will no longer be able to ship them within this current fiscal third quarter and/or our fiscal year.

    “As a result of the current customer product delays and market conditions, as well as delays in expected orders, we are lowering our revenue guidance for fiscal 2019 from a range of $30 million to $35 million to a new range of $20 million to $25 million. However, we expect to see an improvement in bookings in our second half, with an increase in backlog heading into our fiscal 2020, which begins June 1, 2019.

    “We believe that the long-term fundamentals for Aehr Test Systems have not changed. We continue to see an increase in semiconductor content in every part of life as well as an increased need for reliability, security, safety, and confidence in those semiconductors and electronic products. We also see the macro trend of semiconductor devices with heterogeneous integration or stacked die increasing the need for reliability and burn-in of devices before they are integrated or stacked into multi-die packages. Aehr Test’s unique products allow our customers to test and burn-in their devices with the 100% confidence and traceability which are needed to address the safety, security, and confidence for mission critical applications. We feel we are very well positioned to capitalize on these long-term market trends.”

    *Management Conference **Call and Webcast*
    Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its second quarter fiscal 2019 operating results. To access the call dial *800-458-4121* *(+1 323-794-2093 *outside the United States) and give the participant pass code *1583827*. In addition, a live and archived webcast of the conference call will be available over the Internet at in the Investor Relations section. A replay of the conference call will also be available via telephone beginning approximately two hours after conclusion of the call through 8:00 p.m. ET on January 10, 2019. To access the replay dial-in information, please click here.

    *About Aehr Test Systems*
    Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has over 2,500 systems installed worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTS^TM and FOX-P^TM families of test and burn-in systems and FOX WaferPak^TM Aligner, FOX-XP WaferPak Contactor, FOX DiePak^® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP system is a full wafer contact and singulated die/module test and burn-in system used for burn-in and functional test of complex devices, such as leading-edge memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The WaferPak contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at

    *Safe Harbor Statement*
    This press release contains certain forward-looking statements based on current expectations, forecasts and assumptions that involve risks and uncertainties. These statements are based on information available to Aehr Test as of the date hereof and actual results could differ materially from those stated or implied due to risks and uncertainties. Forward-looking statements include statements regarding Aehr Test’s expectations, beliefs, intentions or strategies regarding the future including statements regarding future market opportunities and conditions, expected product shipment dates, customer orders or commitments and future operating results. The risks and uncertainties that could cause Aehr Test’s results to differ materially from those expressed or implied by such forward-looking statements include, without limitation, general market conditions, customer demand and acceptance of Aehr Test’s products and Aehr Test’s ability to execute on its business strategy. See Aehr Test’s recent 10-K, 10-Q and other reports from time to time filed with the Securities and Exchange Commission for a more detailed description of the risks facing Aehr Test’s business. Aehr Test disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.

    *– Financial Tables to Follow –*

    *Condensed Consolidated Statements of Operations*
    (in thousands, except per share data)
        Three Months Ended   Six Months Ended
        Nov 30,   Aug 31,   Nov 30,   Nov 30,   Nov 30,
          2018       2018       2017       2018       2017  
    Net sales $ 5,911     $ 4,740     $ 7,923     $ 10,651     $ 14,893  
    Cost of sales   3,513       3,187       4,792       6,700       8,844  
    Gross profit   2,398       1,553       3,131       3,951       6,049  
    Operating expenses:                                      
    Selling, general and administrative   1,977       1,879       1,854       3,856       3,645  
    Research and development   986       1,116       1,090       2,102       2,045  
    Total operating expenses   2,963       2,995       2,944       5,958       5,690  
    (Loss) income from operations   (565 )     (1,442 )     187       (2,007 )     359  
    Interest expense, net   (74 )     (78 )     (105 )     (152 )     (212 )
    Other income (expense), net   29       9       (7 )     38       (67 )
    (Loss) income before income tax expense   (610 )     (1,511 )     75       (2,121 )     80  
    Income tax expense   (19 )     (4 )     (15 )     (23 )     (10 )
    Net (loss) income   (629 )     (1,515 )     60       (2,144 )     70  
    Less:  Net income attributable to the                                      
      noncontrolling interest   -       -       -       -       -  
    Net (loss) income attributable to Aehr Test                                      
      Systems common shareholders $ (629 )   $ (1,515 )   $ 60     $ (2,144 )   $ 70  
    Net (loss) income per share                                      
    Basic $ (0.03 )   $ (0.07 )   $ 0.00     $ (0.10 )   $ 0.00  
    Diluted $ (0.03 )   $ (0.07 )   $ 0.00     $ (0.10 )   $ 0.00  
    Shares used in per share calculations:                                      
    Basic   22,294       22,190       21,645       22,242       21,531  
    Diluted   22,294       22,190       22,883       22,242       22,937  

    *Reconciliation of GAAP and Non-GAAP Results*
    (in thousands, except per share data)
        Three Months Ended   Six Months Ended
        Nov 30,   Aug 31,   Nov 30,   Nov 30,   Nov 30,
          2018       2018       2017     2018       2017
    GAAP net (loss) income   $ (629 )   $ (1,515 )   $ 60   $ (2,144 )   $ 70
    Stock-based compensation expense     224       256       364     480       580
    Non-GAAP net (loss) income   $ (405 )   $ (1,259 )   $ 424   $ (1,664 )   $ 650
    GAAP net (loss) income per diluted share   $ (0.03 )   $ (0.07 )   $ 0.00   $ (0.10 )   $ 0.00
    Non-GAAP net (loss) income per diluted share   $ (0.02 )   $ (0.06 )   $ 0.02   $ (0.07 )   $ 0.03
    Shares used in GAAP diluted shares calculation     22,294       22,190       22,883     22,242       22,937
    Shares used in non-GAAP diluted shares calculation     22,294       22,190       22,883     22,242       22,937
    Non-GAAP net (loss) income is a non-GAAP measure and should not be considered a replacement for GAAP results.  Non-GAAP net (loss) income is a financial measure the Company uses to evaluate the underlying results and operating performance of the business.  The limitation of this measure is that it excludes items that impact the Company's current period net income.  This limitation is best addressed by using this measure in combination with net (loss) income (the most directly comparable GAAP financial measure).  These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. 

    We believe these measures enhance investors’ ability to review the company’s business from the same perspective as the company’s management and facilitate comparisons of this period’s results with prior periods.

    *Condensed Consolidated Balance Sheets*
    (in thousands, except per share data)
      November 30,   August 31,   May 31,
      2018   2018   2018
    Current assets:                      
    Cash and cash equivalents $ 14,002     $ 15,864     $ 16,848  
    Accounts receivable, net   3,868       2,272       2,856  
    Inventories   9,983       9,585       9,049  
    Prepaid expenses and other   688       727       703  
    Total current assets   28,541       28,448       29,456  
    Property and equipment, net   1,074       1,174       1,203  
    Other assets   286       266       296  
    Total assets $ 29,901     $ 29,888     $ 30,955  
    *LIABILITIES AND SHAREHOLDERS' EQUITY*                      
    Current liabilities:                      
    Current portion of long-term debt $ 6,110     $ 6,110     $ 6,110  
    Accounts payable   1,953       1,317       1,762  
    Accrued expenses   1,487       1,498       1,646  
    Customer deposits and deferred revenue, short-term   2,068       2,339       1,630  
    Total current liabilities   11,618       11,264       11,148  
    Deferred rent   147       145       63  
    Deferred revenue, long-term   252       359       459  
    Total liabilities   12,017       11,768       11,670  
    Aehr Test Systems shareholders' equity   17,902       18,139       19,305  
    Noncontrolling interest   (18 )     (19 )     (20 )
    Total shareholders' equity   17,884       18,120       19,285  
    Total liabilities and shareholders' equity $   29,901     $   29,888     $   30,955  

    *Aehr Test Systems*
    Ken Spink
    Chief Financial Officer
    (510) 623-9400 x309

    *Investor Relations Contact:*
    Todd Kehrli or Jim Byers
    MKR Group, Inc.
    (323) 468-2300  Reported by GlobeNewswire 4 hours ago.

    0 0

    LYNNWOOD, Wash., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Zumiez Inc. (NASDAQ: ZUMZ) a leading specialty retailer of apparel, footwear, equipment and accessories for young men and women, today announced that management will present at the 2019 ICR Conference at the JW Marriott Orlando Grande Lakes in Orlando, Florida. The presentation is scheduled for Monday, January 14, 2019 at 1:30 pm Eastern Time.  The live webcast can be accessed via the investor relations page of Zumiez website at  To listen to the live webcast, visit the Zumiez website at least 10 minutes in advance to download and install any necessary audio software.*About Zumiez Inc.*

    Zumiez is a leading specialty retailer of apparel, footwear, accessories and hardgoods for young men and women who want to express their individuality through the fashion, music, art and culture of action sports, streetwear, and other unique lifestyles. As of January 5, 2019, we operated 709 stores, including 610 in the United States, 50 in Canada, 41 in Europe and 8 in Australia. We operate under the names Zumiez, Blue Tomato and Fast Times. Additionally, we operate ecommerce web sites at, and

    *Company Contact:*
    Darin White
    Director of Finance &
    Investor Relations
    Zumiez Inc.
    (425) 551-1500, ext. 1337

    *Investor Contact:*
    Brendon Frey
    (203) 682-8200 Reported by GlobeNewswire 4 hours ago.

    0 0


    *Copperstone Resources AB (“Copperstone” or “the Company”) is pleased to announce that the Company has signed a 5-year 25 MSEK credit facility. In addition a non-binding term sheet regarding a convertible debt facility of 100 MSEK has been signed with a US-based fund. Upon the convertible debt facility becoming binding and the first tranche of 22.5 MSEK has been paid out, closing of the Viscaria acquisition is anticipated to occur shortly thereafter. In total, up to 125 MSEK will thereby be secured to finance the further development of New Copperstone including Viscaria.*

    Fenomena AB has agreed to a credit facility, for the Viscaria acquisition, of 25 MSEK at 5% annual interest rate to be amortized, no later than, at the earlier of First Copper from Viscaria or 10 January 2024.

    Copperstone has also signed a non-binding term sheet regarding a convertible debt facility of 100 MSEK with a mid-tier US-based fund.  Main terms and conditions of the convertible debt facility are: The debt commitment is divided in tranches of maximum 20-22,5 MSEK. The convertible debt notes held by the fund can be converted to Copperstone B-shares. Further tranches, should Copperstone opt to, can be drawn once the former tranche has been converted into shares. The conversion price is defined as the lower of 1.6 SEK/share and 93% of the 15-day low volume weighted average price of Copperstone prior to conversion. The convertible debt facility is non-interest bearing, the called upon tranche of the convertible facility will instead be subject to a fee of 4.5 percent of the total nominal amount.

    Subject to the signing of the final agreement the financing through the first tranche of 22.5 MSEK, together with the above mentioned credit facility, will suffice to Close the Viscaria acquisition.

    “I am pleased to bring forward Fenomena AB, originating from my hometown of Haparanda, as anchor investor. The convertible debt financing will contribute to the closing as well as to necessary working capital in the future. Thanks to this, the Copperstone team spirit, Regin Corporate Finance and Sunstone’s shared vision of New Copperstone, we are hereby taking a giant leap towards closing of the Viscaria acquisition, the largest underground copper mine in northern Europe in the 1980’s, while at the same time limiting upfront shareholder dilution to an absolute minimum”, comments Michael Mattsson, CEO of Copperstone.

    For further information, please contact Chief Executive Officer Michael Mattsson, +46 705 739 777, or visit the Copperstone website at

    This press release contains insider information which Copperstone Resources AB (publ) is obliged to publish according to the EU market abuse regulation (MAR). This information was submitted for publication, through the above contact person’s agency, 22:05 CET on 10 January 2019.


    Copperstone is a public company trading as COPP B on NASDAQ First North (Stockholm). The Certified Adviser is Augment Partners AB,, +46 8 505 65 172. The Company is focused on base and precious metal exploration in the vicinity of the internationally recognized mining region of the Skellefte-field in northern Sweden. In this area Copperstone owns two exploitation concessions, namely Svartliden k no. 1 (36ha), Eva k no. 1 (34ha) and two nearby exploration permits, namely Sandberget 200 (19ha) and Sandberget 300 (19ha). The Company has also recently applied for two new exploration permits, namely Sandberget 400 (535ha) and Sandberget 500 (7641ha) to form a contiguous block with existing titles. The project is based on 273 drillholes with an approximate total of 46,350m. In addition the Company also owns the Tvistbogruvan K no. 1 (11ha) exploitation concession and the Såggården No.1 (199ha) exploration permit in the Bergslagen mining region of central Sweden. Quoted surface areas are approximate to the nearest hectare.


    · 190110 PR New Copperstone Reported by GlobeNewswire 4 hours ago.

    0 0

    MONTREAL, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Champion Iron Limited (TSX: CIA) (ASX: CIA) (“Champion Iron” or “The Company”) is pleased to announce the appointment of Michael Marcotte as Vice-President, Investors Relations. Michael joins Champion Iron from Macquarie Capital Markets Canada Ltd. (“Macquarie”) where he spent nearly 15 years with a career focus on Canadian resource equities. In his tenure at Macquarie, Michael gained extensive experience engaging institutional investors across North America and Europe. In addition to his experience at Macquarie, Michael also spent some time working in asset management, focusing on resource equities. Michael is a Chartered Financial Analyst, holds a B.Comm from Concordia University and was awarded the 2017 ‘Top-Gun’ award by Brendan Wood International as leading institutional salesperson in Canada.

    “On behalf of the Board of Directors and myself, we extend a warm welcome to Michael and are confident that he will be an integral part of our management team,” commented Michael O’Keeffe, Champion Iron’s Executive Chairman of the Board and CEO. “Michael joins us at a crucial time in our growth cycle, with the Bloom Lake Mine in commercial production. Michael’s knowledge of capital markets will undoubtably ensure an effective Investor Relations program is implemented in the coming months, and we are excited to have Michael lead this important role of communicating Champion Iron’s activities to both existing and future shareholders,” added Mr. O’Keeffe. 

    *About Champion Iron Limited*

    Champion is a producing iron development and exploration company, focused on developing its significant iron resources in the south end of the Labrador Trough in the province of Quebec. Following the acquisition of its flagship asset, the Bloom Lake iron ore property, the Company implemented upgrades to the mine and processing infrastructure and has partnered in projects associated with improving access to global iron markets, including rail and port infrastructure initiatives with government and other key industry and community stakeholders. Champion’s management team includes professionals with mine development and operations expertise, who also have vast experience from geotechnical work to green field development, brown field management including logistics development and financing of all stages in the mining industry.

    *For further information please contact:*

    Michael Marcotte, Vice-President, Investor Relations 514-316-4858, Ext. 128

    For additional information on Champion Iron Limited, please visit our website at:

    *Forward-Looking information*

    This news release includes certain information that may constitute “forward-looking information” under applicable Canadian securities legislation. All statements, other than statements of historical facts, included in this news release that address the expected restart date of Bloom Lake as well as future activities, events, developments or financial performance constitute forward- looking information. The use of any of the words “will”, “expect”, “anticipate”, “intend”, “believe”, “plan”, “potential”, “outlook”, “forecast”, “estimate” and similar expressions are intended to identify forward-looking information. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information, including the risks identified in Champion’s final short form prospectus relating to a completed equity Offering, annual information form, management’s discussion and analysis and other securities regulatory filings made by Champion on SEDAR (including under the heading “Risk Factors” therein). There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward- looking information. Accordingly, readers should not place undue reliance on forward-looking information. All of Champion’s forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of Champion’s management and information available to management as at the date hereof. Champion disclaims any intention or obligation to update or revise any of its forward-looking information, whether as a result of new information, future events or otherwise, except as required by law. Reported by GlobeNewswire 4 hours ago.

    0 0

    PHILADELPHIA, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Urban Outfitters, Inc. (NASDAQ:URBN), a leading lifestyle products and services company which operates a portfolio of global consumer brands comprised of Anthropologie, BHLDN, Free People, Terrain and Urban Outfitters brands and the Food and Beverage division, today announced net sales for the two and eleven months ended December 31, 2018.Total Company net sales for the two months ended December 31, 2018, increased 5.0% over the same period last year. Comparable Retail segment net sales increased 5%, driven by strong, double-digit growth in the digital channel, partially offset by negative retail store sales. By brand, comparable Retail segment net sales increased 6% at Free People, 5% at Urban Outfitters and 4% at the Anthropologie Group. Wholesale segment net sales increased 3%.

    For the eleven months ended December 31, 2018, total Company net sales increased 10.0% over the same period last year. Comparable Retail segment net sales increased 9%, driven by strong, double-digit growth in the digital channel and positive retail store sales. Wholesale segment net sales increased 10%.

    During the eleven months ended December 31, 2018, the Company opened a total of 17 new retail locations including: 5 Urban Outfitters stores, 5 Free People stores, 4 Anthropologie Group stores and 3 Food and Beverage restaurants; and closed 4 retail locations including: 2 Anthropologie Group stores, 1 Urban Outfitters store and 1 Free People store. During the eleven months ended December 31, 2018, 4 franchisee-owned Urban Outfitters stores were opened.

    Urban Outfitters, Inc., offers lifestyle-oriented general merchandise and consumer products and services through a portfolio of global consumer brands comprised of 249 Urban Outfitters stores in the United States, Canada, and Europe and websites; 228 Anthropologie Group stores in the United States, Canada and Europe, catalogs and websites; 136 Free People stores in the United States, Canada and Europe, catalogs and websites, 13 Food and Beverage restaurants, and 4 Urban Outfitters franchisee-owned stores, as of December 31, 2018. Free People, Anthropologie Group and Urban Outfitters wholesale sell their products through approximately 2,100 department and specialty stores worldwide, digital businesses and the Company’s Retail segment.

    *This news release is being made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.* Certain matters contained in this release may constitute forward-looking statements. When used in this release, the words “project,” “believe,” “plan,” “will,” “anticipate,” “expect” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any one, or all, of the following factors could cause actual financial results to differ materially from those financial results mentioned in the forward-looking statements: the difficulty in predicting and responding to shifts in fashion trends, changes in the level of competitive pricing and promotional activity and other industry factors, overall economic and market conditions and worldwide political events and the resultant impact on consumer spending patterns, the effects of the implementation of the United Kingdom's referendum to withdraw membership from the European Union (commonly referred to as “Brexit”), including currency fluctuations, economic conditions, and legal or regulatory changes, any effects of war, terrorism and civil unrest, natural disasters or severe or unseasonable weather conditions, increases in labor costs, increases in raw material costs, availability of suitable retail space for expansion, timing of store openings, risks associated with international expansion, seasonal fluctuations in gross sales, the departure of one or more key senior executives, import risks, changes to U.S. and foreign trade policies, including the enactment of tariffs, border adjustment taxes or increases in duties or quotas, the closing or disruption of, or any damage to, any of our distribution centers, our ability to protect our intellectual property rights, risks associated with digital sales, our ability to maintain and expand our digital sales channels, response to new store concepts, our ability to integrate acquisitions, failure of our manufacturers and third-party vendors to comply with our social compliance program, changes in our effective income tax rate, the impact of the U.S. Tax Cuts and Jobs Act, changes in accounting standards and subjective assumptions, regulatory changes and legal matters and other risks identified in the Company’s filings with the Securities and Exchange Commission. The Company disclaims any intent or obligation to update forward-looking statements even if experience or future changes make it clear that actual results may differ materially from any projected results expressed or implied therein.

    Oona McCullough
    Director of Investor Relations
    (215) 454-4806 Reported by GlobeNewswire 4 hours ago.

    0 0

    PORTLAND, Ore., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Electro Scientific Industries, Inc. (NASDAQ: ESIO), an innovator in laser-based manufacturing solutions for the micro-machining industry, announced that at a Special Meeting of Shareholders held earlier today, ESI shareholders voted to approve the previously announced definitive merger agreement with MKS Instruments, Inc. (NASDAQ: MKSI).Upon consummation of the transaction, ESI shareholders will receive $30.00 per share, in cash, for a total of approximately $1 billion. All necessary regulatory and shareholder approvals are now complete, and subject to the satisfaction of certain remaining customary closing conditions, the transaction is expected to close in early February 2019. Upon the closing of the transaction, trading of ESI’s shares on NASDAQ will cease.

    *About ESI, Inc.*

    ESI enables our customers to commercialize technology using precision laser processes. ESI’s solutions produce the industry’s highest quality and throughput and target the lowest total cost of ownership. ESI is headquartered in Portland, Oregon, with global operations and subsidiaries in Asia, Europe and North America. More information is available at

    *Cautionary Note Regarding Forward-Looking Statements *

    This communication, and any documents to which ESI refers you in this communication, contains not only historical information, but also forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements represent ESI’s current expectations or beliefs concerning future events, including but not limited to the expected completion and timing of the proposed transaction. Without limiting the foregoing, the words “expects,” “may,” “will,” and similar expressions are intended to identify forward-looking statements.  You should read any such forward-looking statements carefully, as they involve a number of risks, uncertainties and assumptions that may cause actual results to differ significantly from those projected or contemplated in any such forward-looking statement.  Those risks, uncertainties and assumptions include, (i) the risk that the proposed transaction may not be completed in a timely manner or at all, which may adversely affect ESI’s business and the price of the common stock of ESI, (ii) the failure to satisfy any of the conditions to the consummation of the proposed transaction, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (iv) the effect of the announcement or pendency of the proposed transaction on ESI’s business relationships, operating results and business generally, (v) risks that the proposed transaction disrupts current plans and operations and the potential difficulties in employee retention as a result of the proposed transaction, (vi) risks related to diverting management’s attention from ESI’s ongoing business operations, (vii) the outcome of any legal proceedings that may be instituted against us related to the merger agreement or the proposed transaction, (viii) unexpected costs, charges or expenses resulting from the proposed transaction, and (ix) other risks described in ESI’s filings with the SEC, such as its Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K.  Forward-looking statements speak only as of the date of this communication or the date of any document incorporated by reference in this document.  Except as required by applicable law or regulation, ESI does not assume any obligation to update any such forward-looking statements whether as the result of new developments or otherwise.


    Erica Mannion or Michael Funari
    Sapphire Investor Relations, LLC
    617-542-6180 Reported by GlobeNewswire 3 hours ago.

    0 0

    NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

    *Edison International (NYSE: EIX)
    Class Period: *February 23, 2016 - November 12, 2018
    *Lead Plaintiff Deadline: *January 15, 2019
    Join the action:

    The lawsuit alleges: Edison International made materially false and/or misleading statements and/or failed to disclose that: (i) the Company failed to maintain electricity transmission and distribution networks in compliance with safety requirements and regulations promulgated under state law; (ii) consequently, the Company was in violation of state law and regulations; (iii) the Company’s noncompliant electricity networks created a significantly heightened risk of wildfires in California; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.To learn more about the *Edison International* class action contact*Altice USA, Inc. (NYSE: ATUS)
    Class Period: *Pursuant and/or traceable to the June 2017 Initial Public Offering
    *Lead Plaintiff Deadline: *January 18, 2019
    Join the action:

    The complaint alleges that the Offering Documents issued pursuant to the IPO failed to disclose and/or misstated material information, including that: (1) “The Altice Way” proprietary growth model previously developed in Europe and described in the Offering Documents as a means to achieve superior margin performance was falsely touting Altice’s capacity to face already existing highly competitive environments and ever-changing consumer behaviors; (2) Altice was suffering from aggressively growing competition both in Europe and the United States, directly causing negative and decelerating revenue and EBITDA growth and impacting Altice’s market share; (3) specifically, Altice was suffering from mismanaged rate events, regulatory compliance and poorly managed network and customer care both in its France and Portugal segments, thereby impacting its customer base and churn rate; (4) Altice USA could not simply replicate the “The Altice Way” in the U.S.; and (5) as a result, Altice USA’s Offering Documents were materially misleading at all relevant times. To learn more about the *Altice USA, Inc.* class action contact have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

    Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

    Levi & Korsinsky, LLP
    Joseph E. Levi, Esq.
    55 Broadway, 10th Floor
    New York, NY 10006
    Tel: (212) 363-7500
    Toll Free: (877) 363-5972
    Fax: (212) 363-7171 Reported by GlobeNewswire 3 hours ago.

    0 0

    Pelican BioThermal's Growing Number of Network Stations and Drop Points Substantially Increases Convenience and Flexibility for Customers Worldwide

    MINNEAPOLIS (PRWEB) January 10, 2019

    Pelican BioThermal, the global name in temperature controlled packaging, announced its global network continues to rapidly expand under the leadership of Dominic Hyde, vice president of Crēdo™ on Demand.

    The Crēdo™ on Demand service is a high performance, cost effective temperature controlled shipper rental program allowing organizations to choose the shipper application that best fits the company’s requirements, logistics profile and budget.

    One year since his appointment, Hyde has overseen significant developments within the expanding rental program and the company’s growing, global footprint of network stations and drop points.

    Hyde said: “My first year with Pelican BioThermal has been extremely positive with ongoing developments benefiting our global customers, who represent eight of the top 10 pharmaceutical manufacturers worldwide. In 2018, we increased our temperature controlled container fleet size by 90%, while increasing our revenue by 90% and we are well positioned to further accelerate our growth in 2019.”

    “Our growing footprint of network stations and drop points are planned to exceed 100 sites by early 2019, representing a significant investment to support the continuing worldwide growth within the pharmaceutical and biomedical industry,” Hyde continued. “We have been busy in 2018 signing multiple freight forwarders and integrators worldwide, increasing our convenience and flexibility for customers by selecting the best locations and organizations to speed the journey of their temperature controlled shipments around the globe."

    Hyde ended with, “I look forward to the exciting developments planned for 2019 as Pelican BioThermal continues to lead the market with its innovative technology and advanced passive systems.”

    Pelican BioThermal’s reusable Crēdo™ on Demand shippers offer a high performance, flexible rental option for temperature controlled containers, such as the Crēdo™ Cargo.

    Its existing and expanding network of service centers, network stations and rental drop-off points span Europe, Asia and the Americas, providing customers with an additional option for returning Crēdo on Demand assets at the end of the rental period, including Crēdo™ Xtreme and Crēdo Cargo temperature controlled containers.

    Visit to learn more about the wide range of Pelican BioThermal products and offerings.

    Pelican BioThermal is a division of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.

    For further information please contact Steph Haugan at 612-334-5960 or email steph.haugan(at)wordsatwork(dot)com

    About Pelican Products
    Pelican Products, Inc. is the global leader in the design and manufacture of high performance protective cases, temperature controlled packaging solutions, advanced portable lighting systems and rugged gear for professionals and outdoor enthusiasts. Their products are used by professionals in the most demanding markets including fire safety, law enforcement, defense / military, aerospace, entertainment, industrial and consumer. Pelican™ products are designed and built to last a lifetime. The company operates in 21 countries, with 22 international sales offices and six manufacturing facilities around the globe. In Europe, the company does business under the name Peli Products, S.LU.  For more information, visit or

    About Pelican BioThermal
    Pelican BioThermal LLC offers the widest range of temperature controlled packaging and service solutions to the global life sciences industry. The company’s products ensure that delicate biological materials arrive intact and effective, despite exterior environments. Pelican BioThermal is dedicated to developing innovative products designed to fulfill the complex needs of the global life sciences industry. The company’s customers benefit from its extensive expertise in ensuring that temperature stability is maintained throughout the distribution chain. The company also offers a complete portfolio of services and software to support end-to-end temperature-controlled packaging asset management. In Europe, the company does business under the name Peli BioThermal Limited. For more information, visit

    All trademarks are registered and/or unregistered trademarks of Pelican Products, Inc., its subsidiaries and/or affiliates and others. Reported by PRWeb 3 hours ago.

    0 0

    Mexico's Diego Lainez Secures Transfer From Club America to Real Betis Diego Lainez has secured his move to Europe, with the 18-year-old Mexican star transferring from Club America to Real Betis in La Liga. Reported by 3 hours ago.

    0 0

    Rolls-Royce's CEO explains how his company just set a new all-time record for sales of its ultra-luxury cars· *On Wednesday, Rolls-Royce Motor Cars reported annual sales of 4,107 vehicles in 2018. It's the most in the ultra-luxury brand's 115-year history. *
    · *This marks a 22% increase over the 3,362 cars sold by the BMW Group subsidiary in 2017. *
    · *Rolls-Royce Motor Cars CEO Torsten Müller-Ötvös attributes the growth to the arrival of the new eighth-generation flagship Phantom sedan.*

    On Wednesday, Rolls-Royce Motor Cars reported annual sales of 4,107 vehicles in 2018. It's the most in the ultra-luxury brand's 115-year history. 

    BMW Group's Goodwood, England-based subsidiary beat out the previous record of 4,063 cars set back in 2014. 

    This marks a 22% increase over the 3,362 cars "commissioned" by the company's clients in 2017. 

    Much of the growth was driven by the debut and production ramp-up of the eighth generation of the company's flagship Phantom sedan, Rolls-Royce Motor Cars CEO Torsten Müller-Ötvös told Business Insider in an interview on Wednesday. 

    (Rolls-Royce Motor Cars is not affiliated with Rolls-Royce Holdings plc, which is an aviation engine maker and defense contractor.) 

    *Read more*: We drove the all-new $644,000 Rolls-Royce Phantom and were blown away by its opulence. Take a look inside.

    North America remains Rolls-Royce's largest market and accounts for roughly one-third of the company's total sales, Müller-Ötvös said. 

    Europe and Asia each accounted for 20% of worldwide sales. China proved to be a particularly bright spot with a 40% surge in sales in 2018 on the back of strong Phantom and Ghost sedan sales, the CEO explained.

    The UK also saw sales jump 10% in spite of economic and political instability. 

    As for 2019, Müller-Ötvös expects Rolls-Royce to have another banner year with full-scale production of the new Cullinan SUV coming online.

    According to the company's longtime CEO, the order backlog of the Cullinan has reached the third quarter of 2019 and will be the brand's best selling model. 

    *SEE ALSO: We drove an all-new $644,000 Rolls-Royce Phantom that's the pinnacle of automotive luxury. Here are its coolest features.*

    *FOLLOW US: On Facebook for more car and transportation content!*

    Join the conversation about this story »

    NOW WATCH: These bespoke metal cars take 2,000 hours to make by hand — see the step-by-step process Reported by Business Insider 3 hours ago.

    0 0

    Britain overtakes Germany to become the vegan capital of Europe Analysis shows that more and more UK consumers are completely ditching meat, dairy and eggs from their diet, one in three of the total population have been cutting back on food consumption. Reported by MailOnline 3 hours ago.

    0 0

    ValvTechnologies, Inc., the global leader in the design and manufacturing of zero-leakage high-performance isolation valve solutions, is proud to announce its Nuclear Industry Director, Bill Henwood, will be a featured speaker at the 2019 Fluid Leak Management Users Group conference.

    HOUSTON (PRWEB) January 10, 2019

    The conference and expo event will bring air operated valve (AOV), motor operated valve (MOV), fluid leak management (FLMUG), boric acid and compressed air nuclear leaders together on January 14-18 at the JW Marriott Desert Springs Resort in Palm Desert, California. An assembly of respective program engineers, equipment reliability managers, procurement engineers and concerned industry leaders will share their expertise on key topics ranging from nuclear utility projects to the development of plant improvement programs and solutions implemented.

    Henwood will present a case study focusing on the ongoing efforts at Sizewell B Nuclear Power Station to replace linear valve technology with quarter-turn isolation technology and the revenue generated from these efforts.

    "Members of the nuclear community will gain insight into how they can effectively implement a similar program resulting in megawatt recovery, vastly improved safety of plant personnel, the elimination of costly spare parts, valves, maintenance and warranty claims. It is also timely with respect to the Nuclear Promise”, Henwood said.

    For additional event information, visit:
    For more information about ValvTechnologies, visit:

    About ValvTechnologies

    Founded in 1987 and headquartered in Houston, Texas, ValvTechnologies is the leading manufacturer of zero-leakage, high-performance isolation valve solutions. Employing more than 500 people worldwide, our offices are located in Australia, Canada, China, Eastern Europe, Western Europe, India, Japan, Korea, Latin America, the Middle East, United Kingdom and United States. In addition, ValvTechnologies partners with stocking distributors and independent representatives to service customers around the world.

    To find out more about the products and services offered or to locate a representative, visit our website at and connect with ValvTechnologies on Twitter, LinkedIn and Facebook. Reported by PRWeb 2 hours ago.

    0 0

    · *NZD/USD has been consolidating a touch above the pivot around 0.6780 and below the 200-4 hr SMA that is tucked in just below the prior day's highs of 0.6813.***
    · *In early Asia, NZD/USD is currently trading at 0.6781, with the price capped by the 200-D SMA as bulls struggle to make further headway following a bullish start to the year. *

    NZD/USD is ending the first full week of 2019 on a positive note, having climbed back from the flash crash lows and carried the bullish sentiment towards the 0.68 handle as markets position for a far slower pace of rate hikes from the Fed. However, as analysts at ANZ Bank explained, the bird is facing a tug of war:

    "The kiwi is facing a tug of war, with a more dovish Fed, slowing Chinese growth, trade developments and event risk all buffeting the NZD. We retain a medium-term downward bias but don’t expect the path to be straightforward from here."

    Similarly, while the market is pricing out Fed hikes, what should be noted is that the markets are greatly more dovish than what the Fed appears to be and somewhat more pessimistic than the Fed's growth projections for the US economy. It is more the global economy that the Fed is concerned for and the implications for the US economy down the line rather than the immediate future. There are plenty of risks offshore though, associated with world trade disputes as well as Brexit and poor economic growth outlooks on mainland Europe. Te wait and see approach from the Fed does not rule out rate hikes and it may not take much to tip the balance should something flare up overseas, supporting the safe haven and yield case for the dollar once again. 

    *NZD/USD levels*

    · Support 0.6650.
    · Resistance 0.6860.


    Bulls still struggle at the 0.68 handle still but should there be a surge higher, then the 50% Fibo is located at 0.6929. This is guarding the December high of 0.6969. On the flip side, a break of the 100-D SMA at 0.6681 with daily closes will sure up the negative bias again, especially on a break back below the 23.6% Fibo. Reported by 2 hours ago.

    0 0

    Smartphone giant Xiaomi Corp is looking to sharpen its operations in Europe this year, as the US-China trade war casts a shadow on its expansion plans in the world’s biggest economy. “The European market is our main focus for international expansion this year,” Lei Jun, the chairman and chief executive of Hong Kong-listed Xiaomi, said in an interview in Beijing on Thursday, sidestepping a question about the firm’s activities in the US. “We aim to rank [either]... Reported by S.China Morning Post 2 hours ago.

    0 0

    The broadcasts, which begin on Friday with Cadiz's game against Granada, will be available in Africa, Asia, the Americas and the rest of Europe but not in Spain, where they will continue to be shown on national television. Reported by SBS 1 hour ago.

    0 0

    San Francisco employment attorney Charles O. Thompson has moved to global law firm Greenberg Traurig, LLP as a shareholder, further strengthening the firm’s Global Labor and Employment Practice.

    SAN FRANCISCO (PRWEB) January 10, 2019

    San Francisco employment attorney Charles O. Thompson has moved to global law firm Greenberg Traurig, LLP as a shareholder, further strengthening the firm’s Global Labor and Employment Practice. Thompson, a seasoned employment trial lawyer, was formerly managing partner of Polsinelli’s San Francisco office and chair of its Class Action Practice. He has extensive experience litigating employment-related issues for public and private companies, having handled over 1,000 employment matters for clients ranging from Fortune 500 companies to Silicon Valley startups.

    “Chuck’s broad experience and reputation as one of the nation’s leading labor and employment attorneys further enhance and complement our strong and growing presence in the western states’ labor and employment community,” said Chuck Birenbaum, who serves as Greenberg Traurig’s chair of Northern California. “We are experiencing strong client demand in class actions and high exposure cases, leading us to reach out to experts like Chuck Thompson. We are thrilled to welcome him to our San Francisco office.”

    Thompson focuses his practice on employment litigation and counseling clients through all phases of Class Actions and Single Plaintiff cases. He has tried employment, commercial, and professional liability cases to verdict and directed verdict, and has litigated and appealed cases from California State Courts to the United States Supreme Court. He represents employers in all facets of wage/hour cases, as well as class actions brought by the EEOC in state and federal courts across the United States and has broad experience appearing before the California Department of Fair Employment and Housing, the Division of Labor Standards Enforcement, the Employment Development Department, and the United States Equal Employment Opportunity Commission and the Department of Labor. His areas of concentration include matters involving the Americans with Disabilities Act, sexual harassment and assault, discrimination and wrongful termination, wage and hour, and catastrophic cases.

    “We are very focused on building our west coast labor and employment practice to meet increasing client demand; and hiring Charles, a highly-regarded and credentialed attorney, reflects our ability to identify and recruit talented practitioners as we position ourselves to address the needs of clients in a changing global market,” noted Naomi G. Beer, co-chair of Greenberg Traurig’s Global Labor and Employment Practice.

    In addition to his trial and counseling work, Thompson has served as a judicial mediator and arbitrator, and has acted as a pro-tem judge upon request of the court. He is recognized as a thought leader in his field, regularly invited to lecture on civil litigation subjects, including all facets of employment litigation, trial strategy, effective discovery techniques, and ethics.

    Throughout his career, Thompson has been a champion for diversity. He is an executive committee member of the Justice and Diversity Committee of the San Francisco Bar and led the Western Region diversity committee at his former firm. He actively supports and promotes diversity efforts and collaborates with clients on diversity issues. Thompson earned his J.D. from Golden Gate University School of Law and his B.S. from University of San Francisco.

    “I am excited to be joining Greenberg Traurig, with its strong reputation in the area of employment law as well as its incredible platform both geographically and across practice areas,” Thompson said. “I look forward to collaborating with my colleagues in California and across the firm.”

    About Greenberg Traurig’s Labor & Employment Practice: Greenberg Traurig’s Global Labor & Employment Practice serves clients from offices throughout the United States, Latin America, Europe, and Asia. Members of the practice have had numerous trial wins and are frequently called upon to handle complex, bet-the-company, and large high-stake cases, including class and collective actions. On the labor side, a leading group of lawyers regularly represents management with labor-relations matters. Labor & Employment team members assist clients with complex employment issues, and design practical, proactive strategies that can be readily implemented by today’s human resources professionals. In addition, the practice is recognized by The Legal 500 United States in the areas of Labor and Employment Litigation, Labor-Management Relations, ERISA Litigation, Workplace & Employment Counseling, and Trade Secrets Litigation. Visit Greenberg Traurig’s Labor & Employment Blog for insights and analysis of the latest labor and employment developments, including legislation, regulations, cases, policies, and trends.

    About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2018 Am Law Global 100. Web: Twitter: @GT_Law. Reported by PRWeb 1 hour ago.

older | 1 | .... | 1624 | 1625 | (Page 1626) | 1627 | 1628 | .... | 1652 | newer